MRD / Regn No. : 20260000543 Date : 16/06/2026
Patient Name : Rupesh Chandra Deb Age & Gender : 55 Yrs. / Male
Contact No. : 6295851621 UHID :
Ht / Wt / BMI : 164 / 71 / 26.40 BP S / BP D : 130 / 60
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (16/Jun/2017) |
Subjective : DM SINCE 2018,DYSESTHESIA POST WALKING
Objective : NONE
Analysis : TYPE 2 DM,DYSLIPIDEMIA
Plan : CHANGE TO GLP1RA SGLT2I  
Salient Investigations : EJECTION FRACTION: 62 % | E / E PRIME: 10
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET SEMAGLUTIDE 3 MG
SEMALIX 3 MG
Medicine For DIABETES 		PO 1-0-0 EMPTY STOMACH NO INTAKE FOR 30 MINUTES
MAY CAUSE NAUSEA OR VOMITING
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION 		PO 1-0-0 BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL 		PO 0-0-1 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
       
Refill : 0 / Substitution:    
Education : AVOID CONJEE SWEETS CHOCOLATES AND SIMPLE SUGARS OF ANY KIND,AVOID OR REDUCE RESTAURANT FOOD,AVOID PROCESSED FOOD,EXERCISE 150 MINUTES PER WEEK,REDUCE CARBOHYDRATE BY 20%,REDUCE SEDENTARY TIME
Next Visit : 16/Jul/2026
Tests Suggested For Next Visit :
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: